NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics (Discontinued)

NIH R01, R21, R33, SBIR/STTR Grants for Sepsis Research is sponsored by National Institutes of Health (NIH). NIH offers multiple open calls for sepsis research, including basic, translational, and clinical studies, as well as small business innovation. This can include projects on developing novel tools and technologies for sepsis research and detection, which may involve clinical decision support systems.

National Institute of General Medical Sciences (NIGMS) Small Business (SBIR/STTR) grants is sponsored by National Institute of General Medical Sciences (NIGMS). NIGMS funds small business (SBIR/STTR) grants within its scientific mission areas. While NIGMS primarily supports basic biomedical research not targeted to specific diseases, it encourages applications that align with its mission to understand fundamental biological processes, which can underpin advancements in women's health diagnostics.

Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) - National Institute of General Medical Sciences (NIGMS) is sponsored by National Institute of General Medical Sciences (NIGMS) / National Institutes of Health (NIH). NIGMS supports innovative SBIR/STTR projects that could benefit research communities related to its mission, focusing on basic research that increases understanding of biological processes. This includes technology development for biomedical research and multi-scale computational modeling, bioinformatics, and biostatistics.

NIGMS-Specific SBIR Guidance (within NIH SBIR/STTR) is sponsored by National Institute of General Medical Sciences (NIGMS), NIH. NIGMS supports innovative SBIR projects that benefit research communities related to its mission. These are investigator-initiated, allowing applicants to propose their research, methodology, and commercialization path. Applications are accepted in most scientific areas supported by NIGMS.

Small Business Grant Programs: SBIR and STTR (NIGMS) is a grant from the National Institute of General Medical Sciences (NIGMS) at NIH that funds small business research and development projects with strong potential for commercialization in the life sciences and biomedical fields. NIGMS supports investigator-initiated SBIR/STTR applications across most scientific areas within its mission, including basic biomedical research topics. Phase 1 grants (R41/R43) establish scientific and technical feasibility; Phase 2 grants (R42/R44) continue R&D initiated in Phase 1. Eligible applicants are U.S. small businesses meeting SBA size standards. Budget requests must not exceed statutory SBIR/STTR limits unless the project fits SBA-approved waiver topics. NIGMS also participates in the Commercialization Readiness Pilot (CRP) program to help Phase 2 awardees reach commercialization.

NINDS Small Business Program Areas of Interest - Therapeutics and Diagnostics Development for Neurological Disorders is sponsored by National Institute of Neurological Disorders and Stroke (NINDS) / NIH. The NINDS SBIR/STTR program funds small business concerns to conduct innovative neuroscience research and development with commercialization potential and public benefit. This includes therapeutics and diagnostics development for neurological disorders, which can encompass preclinical drug development for Alzheimer's disease.